An RCT Promoting HPV Vaccination Among Chinese MSM
NCT03286907 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 624
Last updated 2020-06-18
Summary
Objectives:
To evaluate efficacies of two online and theory-based interventions \[HC: health communication only and HC-MI health communication plus motivational interviewing (MI)\] in increasing uptake of three doses of HPV vaccines within the 9-month follow-up period among Hong Kong Chinese men who have sex with men (MSM).
Hypothesis:
The HPV vaccination rate of the three groups would be in the order HC-MI group \> HC group \> Control group.
Design and subjects:
A three-arm randomized controlled trial (RCT) will be conducted (n= 624). With informed consent, anonymous surveys will be conducted at baseline, Months 3, 6, and 9. Inclusion criteria: 1) HK Chinese men aged \>18, 2) oral or anal intercourse with men in the last six months; 3) no intention to leave HK for one month consecutively within the next 12 months, 4) regular internet access, and 5) willing to be followed up by phone.
Study instruments:
Structured questionnaires
Interventions:
1\) Group HC: exposure to web-based, interactive and theory-based health communication promoting HPV vaccination uptake; 2) Group HC-MI: same exposure as Group HC plus MI; and 3) Group C: exposure to online materials about mental health (control group).
Main outcome measures:
Uptake of three doses of HPV vaccination within the follow-up period.
Data analysis and expected results:
Intention-to-treat analysis, General Estimation Equation (GEE) and Cox regression methods will be used. Significance differences in HPV vaccination uptake rates will be found among the three groups.
Conditions
- Health Behavior
Interventions
- BEHAVIORAL
-
Online videos
Watch two online short health promotion videos (five minutes each), complete a self-administered online exercise and receive reminders at month 1, 2, 4, 6 \& 8.
- BEHAVIORAL
-
Online videos and MI
Watch two online short health promotion videos (five minutes each), complete a self-administered online exercise, receive 15 minutes motivational interviewing through telephone and reminders at month 1, 2, 4, 6, \& 8.
- BEHAVIORAL
-
Control group
Receive online health communication messages about prevalence of some common mental health problems among MSM and introduction of stress reduction exercises
Sponsors & Collaborators
-
Chinese University of Hong Kong
lead OTHER
Principal Investigators
-
Zixin Wang, PhD · Centre for Health Behaviours Research, JC School of Public Health and Primary Care, The Chinese University of Hong Kong
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-08-01
- Primary Completion
- 2019-12-31
- Completion
- 2019-12-31
Countries
- Hong Kong
Study Locations
More Related Trials
-
Immunogenicity and Safety of a Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Hib Vaccine in 13-59 Months Old Healthy Children
NCT01125527 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity Study of Recombinant Trivalent Rotavirus Subunit Vaccine in Healthy Infants and Toddlers
NCT05621655 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Edtech-HPV: A Community Approach Using Education and Technology to Increase HPV Vaccination
NCT03209713 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Study to Evaluate the Reactogenicity and Safety of Rotarix™ in Chinese Adults
NCT01162590 ·Status: COMPLETED ·Phase: PHASE1
-
A Controlled Trial to Assess the Immunogenicity of a Proposed Paediatric Dosing Schedule of Human Papillomavirus Vaccine
NCT00501137 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity of DTaP-IPV/Hib Pentavalent Vaccine in Chinese 2-month-old Infants
NCT06605755 ·Status: RECRUITING ·Phase: NA
-
Immunogenicity and Safety Study of Booster Dose of GSK Biologicals' IPV (Poliorix™) and DTPa/Hib (Infanrix+Hib™) Vaccine
NCT01449812 ·Status: COMPLETED ·Phase: PHASE3
-
Typhoid Vi Vaccine Effectiveness in Hechi, Guangxi, China
NCT00131833 ·Status: COMPLETED ·Phase: PHASE4
-
Immunogenicity and Safety of Booster Dose of PoliorixTM Vaccine in Previously Vaccinated Toddlers
NCT01323647 ·Status: COMPLETED ·Phase: PHASE3
-
The Efficacy of Digital Educational Interventions on Parental HPV Knowledge and Attitude, and Their Children's Vaccination Rates
NCT06341738 ·Status: COMPLETED ·Phase: NA
-
Immunogenicity and Safety of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine in Infants and Children
NCT01428908 ·Status: COMPLETED ·Phase: PHASE3
-
The Safety and Immunogenicity Study of Rotavirus Vaccine Simultaneously Vaccinated With MR or MMR Vaccine
NCT02153866 ·Status: UNKNOWN ·Phase: PHASE4
-
Trail To Evaluate the Immune Effects of Primary and Booster Immunizations With Poliovirus Vaccine
NCT03821441 ·Status: UNKNOWN ·Phase: PHASE3
-
Clinic Trial to Evaluate the Safety and Immunogenicity by Different Sequential Schedules of bOPV and IPV
NCT03614702 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Immunization Schedules of Inactivated Hepatitis A Vaccine and Combined Hepatitis A and Hepatitis B Vaccine
NCT02445703 ·Status: COMPLETED ·Phase: PHASE4
-
To Evaluate the Immunogenicity and Safety of Inactivated Hepatitis A Vaccine
NCT03654664 ·Status: COMPLETED ·Phase: PHASE3
-
Sequential Inactivated Poliomyelitis Vaccine Followed by Oral Poliomyelitis Vaccine Versus Oral Poliomyelitis Vaccine
NCT01475539 ·Status: COMPLETED ·Phase: PHASE4
-
Educational Intervention to Improve HPV Vaccination Decision Quality
NCT02797054 ·Status: COMPLETED ·Phase: NA
-
Immunogenicity and Safety Study of GSK Biologicals' Infanrix-IPV+Hib™ Vaccine
NCT01086423 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess the Efficacy, Immunogenicity and Safety of Liquid Human Rotavirus Vaccine, in Healthy Chinese Infants
NCT01171963 ·Status: COMPLETED ·Phase: PHASE3
-
Dose Ranging Study of Combined Haemophilus Influenzae Type B-Meningococcal Serogroups CY (Hib-MenCY-TT) Vaccine
NCT00127855 ·Status: COMPLETED ·Phase: PHASE2
-
Safety of Two Doses of Avaxim® 80U Pediatric (Inactivated Hepatitis A Vaccine) in Toddlers, Children and Adolescents
NCT02011763 ·Status: COMPLETED ·Phase: PHASE4
-
Safety of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine in Children
NCT01406509 ·Status: COMPLETED ·Phase: PHASE1
-
Child Vaccination Scheduling in China
NCT07141875 ·Status: NOT_YET_RECRUITING
-
The Immunogenicity and Safety of Live Attenuated Poliomyelitis Vaccine (Human Diploid Cell)
NCT02231632 ·Status: COMPLETED ·Phase: PHASE2/PHASE3